Form4insider filings, from the source

SEC Form 4 · accession 0000905148-17-000625

REATA PHARMACEUTICALS INC · RETA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
R Kent McGaughy Jr.
Director · 10% Owner
Period of report
Jun 22, 2017
Accepted (ET)
Jun 23, 2017 · 5:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358762

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A common stockF5,F1,F7Jun 22, 2017C742,289—A2,668,323ISee footnote
Class A common stockF2,F7holding———4,591IBy Lagos Trust
Class A common stockF3,F7holding———280IBy Traweek Children's Trust
Class A common stockF4,F7holding———2,739ISee footnote
Class A common stockholding———25,004D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Class B Common StockF5,F1,F7,F6—Jun 22, 2017P1,200,000A——Class A Common Stock1,200,0002,435,146I
Class B Common StockF5,F1,F7—Jun 22, 2017C742,289D——Class A Common Stock742,2891,692,857I
Class B Common StockF2,F7,F6—holding—————Class A Common Stock51,09551,095I
Class B Common StockF3,F7,F6—holding—————Class A Common Stock3,1093,109I
Class B Common StockF4,F7,F6—holding—————Class A Common Stock30,47830,478I
Class B Common StockF6—holding—————Class A Common Stock278,309278,309D

Explanation of responses